Losing weight, eating well, and exercising will keep you healthy but your butt cellulite is there to stay
Toradol (ketorolac) is a powerful non-steroidal anti-inflammatory medication commonly used to help relieve moderate to severe pain without the use of narcotics or opioids
How it helps disc herniation specifically: Upregulates tendon-related growth factors BPC-157 activates the Egr-1 transcription factor, which drives collagen synthesis in fibrous tissue including the annulus fibrosus Promotes angiogenesis increases VEGF expression, improving blood supply to the avascular disc environment Neuroprotective effects multiple rodent studies show BPC-157 accelerates peripheral nerve regeneration and protects against nerve compression injury Systemic anti-inflammatory suppresses pro-inflammatory cytokine cascades without the immunosuppressive side effects of steroids Protocol: Dose: 250500mcg/day subcutaneous injection Injection site: Lower abdomen or closest accessible subQ site to the injury (though systemic distribution means proximity matters less than for localized joint issues) Duration: 68 weeks loading phase, reassess at week 8 Most people notice reduced nerve pain and improved mobility within 24 weeks
Anyone with digestive issues, low stomach acid or a condition affecting the gut may absorb very little from oral supplements regardless of the dose
These conditions offer a robust justification for novel plans to improve the efficacy of mAbs targeting tumor vasculature, such as antibodydrug conjugates (ADCs) and peptide-drug conjugates (PDCs), offering a new avenue to exert anti-angiogenic effects on cancerous cells
Removal from Category 2 means the FDA no longer considers BPC-157 to pose the level of safety risk that warrants this restriction
